Microbot Medical Financials
| CY9D Stock | 0.91 0.02 2.15% |
Microbot |
Understanding current and past Microbot Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Microbot Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Microbot Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Microbot Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Microbot Medical. Check Microbot Medical's Beneish M Score to see the likelihood of Microbot Medical's management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | Stuttgart Exchange |
| ISIN | US59503A2042 |
| Benchmark | Dow Jones Industrial |
Microbot Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Microbot Medical's current stock value. Our valuation model uses many indicators to compare Microbot Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Microbot Medical competition to find correlations between indicators driving Microbot Medical's intrinsic value. More Info.Microbot Medical is rated below average in current valuation category among its peers. It is rated third in price to book category among its peers . The ratio of Current Valuation to Price To Book for Microbot Medical is about 4,432,106 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Microbot Medical's earnings, one of the primary drivers of an investment's value.Microbot Medical Systematic Risk
Microbot Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Microbot Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Microbot Medical correlated with the market. If Beta is less than 0 Microbot Medical generally moves in the opposite direction as compared to the market. If Microbot Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Microbot Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Microbot Medical is generally in the same direction as the market. If Beta > 1 Microbot Medical moves generally in the same direction as, but more than the movement of the benchmark.
Microbot Medical Thematic Clasifications
Microbot Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Microbot Medical December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Microbot Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Microbot Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Microbot Medical based on widely used predictive technical indicators. In general, we focus on analyzing Microbot Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Microbot Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.0 | |||
| Information Ratio | 0.0212 | |||
| Maximum Drawdown | 13.93 | |||
| Value At Risk | (4.30) | |||
| Potential Upside | 4.6 |
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.